Therapeutic potential of Juglans regia L. leaf extract against diabetic retinopathy in rat


1 Anatomy Department, Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran

2 Molecular and Cell Biology Research Center, Department of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

3 Department of Biochemistry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

4 Razi Herbal Researches Center, Lorestan University of Medical Sciences, Khorramabad, Iran


Objective(s): Oxidative stress has a pivotal role in the pathogenesis of diabetic retinopathy (DR). Juglans regia L. (JRL) leaf extract has hypoglycemic and antioxidative properties. This study aimed to determine the ameliorative effects of JRL against diabetic retinopathy.
Materials and Methods: The DR rat model was generated by injection of streptozotocin (STZ). A subset of the diabetic rats received JRL or metformin after the onset of hyperglycemia. Histopathology and immunohistochemistry of apoptotic and inflammatory factors were assessed along with biochemical assessments of lipid peroxidation and antioxidant status.
Results: Lipid peroxidation level and catalase activity significantly improved after JRL consumption (PPP Conclusion: JRL leaf extract exert protective effects against diabetic retinopathy.


1. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007; 14:179-183.
2. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18:1450-1452.
3. Guzman DC, Olguín HJ, García EH, Peraza AV, de la Cruz DZ, Soto MP. Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress. Redox Rep 2016:1-7.
4. Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R. Pathophysiology of diabetic retinopathy. ISRN Ophthalmol 2013; 2013:343560.
5. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54:1615-1625.
6. Lim TK. Edible medicinal and non-medicinal plants.  Springer Dordrecht Heidelberg London New York, 2012; 3:8661-8667.
7. Sorber DG, Kimball MH. Use of ethylene in harvesting the Persian walnut (Juglans Regia) in California. Issue 996 of Technical bulletin, U.S. Department of Agriculture, 1950.
8. Pereira JA, Oliveira I, Sousa A, Ferreira IC, Bento A, Estevinho L. Bioactive properties and chemical composition of six walnut (J. regia) cultivars. Food Chem Toxicol 2008; 46:2103-2111.
9. Pereira JA, Oliveira I, Sousa A, Valentão P, Andrade PB, Ferreira IC, et al. Walnut (J. regia) leaves: phenolic compounds, antibacterial activity and antioxidant potential of different cultivars. Food Chem Toxicol 2007; 45:2287-2295.
10. Zhao MH, Jiang ZT, Liu T, Li R. Flavonoids in Juglans regia L. leaves and evaluation of in vitro antioxidant activity via intracellular and chemical methods. Scientific World Journal 2014; 2014:303878.
11. Almeida IF, Fernandes E,  Lima JL, Costa PC,  Bahia MF. Walnut (Juglans regia) leaf extracts are strong scavengers of pro-oxidant reactive species. Food Chem 2008; 106:1014-1020.
12. Erdemoglu N, Küpeli E, Yeşilada E. Anti-inflammatory and antinociceptive activity assessment of plants used as remedy in Turkish folk medicine. J Ethnopharmacol 2003; 89:123-129.
13. Carvalho M, Ferreira PJ, Mendes VS, Silva R, Pereira JA, Jerónimo C, et al. Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food Chem Toxicol 2010; 48:441-447.
14. Rather MA, Dar BA, Dar MY, Wani BA, Shah WA, Bhat BA, et al. Chemical composition, antioxidant and antibacterial activities of the leaf essential oil of Juglans regia L. and its constituents. Phytomedicine 2012; 19:1185-1190.
15. Noumi E, Snoussi M, Hajlaoui H, Valentin E, Bakhrouf A. Antifungal properties of Salvadora persica and Juglans regia L. extracts against oral Candida strains. Eur J Clin Microbiol Infect Dis 2010; 29:81-88.
16. Javidanpour S, Fatemi Tabtabaei SR, Siahpoosh A, Morovati H, Shahriari A. Comparison of the effects of fresh leaf and peel extracts of walnut (Juglans regia L.) on blood glucose and β-cells of streptozotocin-induced diabetic rats. Vet Res Forum 2012; 3:251-255.
17. Jelodar G, Mohsen M, Shahram S. Effect of walnut leaf, coriander and pomegranate on blood glucose and histopathology of pancreas of alloxan induced diabetic rats. Afr J Tradit Complement Altern Med 2007; 4:299-305.
18. Asgary S, Parkhideh S, Solhpour A, Madani H, Mahzouni P, Rahimi P. Effect of ethanolic extract of Juglans regia L. on blood sugar in diabetes-induced rats. J Med Food 2008; 11:533-538.
19. Mohammadi J, Delaviz H, Malekzadeh JM, Roozbehi A. The effect of hydro alcoholic extract of Juglans regia leaves in streptozotocin-nicotinamide induced diabetic rats. Pak J Pharm Sci 2012; 25:407-411.
20. Hosseini S, Huseini HF, Larijani B, Mohammad K, Najmizadeh A, Nourijelyani K, et al. The hypoglycemic effect of Juglans regia leaves aqueous extract in diabetic patients: A first human trial. Daru 2014; 22:19.
21. Hosseini S, Jamshidi L, Mehrzadi S, Mohammad K, Najmizadeh AR, Alimoradi H, et al. Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. J Ethnopharmacol 2014; 152:451-456.
22. Pitschmann A, Zehl M, Atanasov AG, Dirsch VM, Heiss E, Glasl S. Walnut leaf extract inhibits PTP1B and enhances glucose-uptake in vitro. J Ethnopharmacol 2014; 152:599-602.
23. Vandendool H, Kratz PD. A generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography. J Chromatogr 1963; 11:463-471.
24. Gong CY, Lu B, Hu QW, Ji LL. Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor. Int J Ophthalmol 2013; 6:573-577.
25. Tzeng TF, Liou SS, Tzeng YC, Liu IM. Zerumbone, a Phytochemical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic Rats. Nutrients 2016; 8: pii:E449.
26. Mihara S, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86:271-278.
27. Aebi H.  Catalase in vitro. Methods Enzymol 1984; 105:121-126.
28. Jiang Y, Walker RJ, Kern TS, Steinle JJ. Application of isoproterenol inhibits diabetic-like changes in the rat retina. Exp Eye Res 2010; 9:171-179.
29. Amaral JS, Seabra RM, Andrade PB, Valentao P, Pereira JA, Ferreres F. Phenolic profile in the quality control of walnut (Juglans regia L.) leaves. Food Chem 2004; 88:373-379.
30. Hosseinzadeh H, Zarei H, Taghiabadi E. Antinociceptive, anti-inflammatory and acute toxicity effects of juglans regia L. Leaves in mice. Iran Red Crescent Med J 2011; 13:27-33.
31. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007; 2007:43603.
32. Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res 1984; 3:223-227.
33. Wu Y, Tang L, Chen B. Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.. Oxid Med Cell Longev 2014; 2014:752387.
34. Pacher P, Obrosova IG, Mabley JG, Szabó C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005; 12:267-275.
35. Solar A, Colarič M, Usenik V, Stampar F. Seasonal variations of selected flavonoids, phenolic acids and quinones in annual shoots of common walnut (Juglans regia L.). Plant Science 2006; 170:453–461
36. Cosmulescu S, Trandafir I, Nour V. Seasonal variation of the main individual phenolics and juglone in walnut (Juglans regia) leaves. Pharm Biol 2014; 52:575-580.
37. Gawlik-Dziki U, Durak A, Pecio Ł, Kowalska I. Nutraceutical potential of tinctures from fruits, green husks, and leaves of Juglans regia L. ScientificWorldJournal 2014;2014: 501392.
38. Eidi A, Moghadam JZ, Mortazavi P, Rezazadeh S, Olamafar S. Hepatoprotective effects of Juglans regia extract against CCl4-induced oxidative damage in rats. Pharm Biol 2013; 51:558-565.
39. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 2003; 37:1169-1180.
40. Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, et al. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci 2007; 48:4342-4350.
41. Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 2007; 56:337-345.
42. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005;54:1559-1565.
43. Borrie SC, Duggan J, Cordeiro MF. Retinal cell apoptosis. Expert Rev Ophthalmol 2009; 4:27-45.
44. Li YH, Zhuo YH, Lü L, Chen LY, Huang XH, Zhang JL, et al. Caspase-dependent retinal ganglion cell apoptosis in the rat model of acute diabetes. Chin Med J (Engl) 2008; 121:2566-2571.
45. Salimi M, Majd A, Sepahdar Z, Azadmanesh K, Irian S, Ardestaniyan MH, et al. Cytotoxicity effects of various Juglans regia (walnut) leaf extracts in human cancer cell lines. Pharm Biol 2012; 50:1416-1422.
46. Alshatwi AA, Hasan TN, Shafi G, Syed NA, Al-Assaf AH, Alamri MS, et al. Validation of the Antiproliferative Effects of Organic Extracts from the Green Husk of Juglans regia L. on PC-3 Human Prostate Cancer Cells by Assessment of Apoptosis-Related Genes. Evid Based Complement Alternat Med 2012; 2012:103026.
47. Hasan TN, B LG, Shafi G, Al-Hazzani AA, Alshatwi AA. Anti-proliferative effects of organic extracts from root bark of Juglans Regia L. (RBJR) on MDA-MB-231 human breast cancer cells: role of Bcl-2/Bax, caspases and Tp53. Asian Pac J Cancer Prev 2011; 12:525-530.